Reports for CHEPLAPHARM ARZNEIMITTEL GMBH
Company Name
CHEPLAPHARM ARZNEIMITTEL GMBH
Totals |
||
Shortage reports |
69 |
|
| Actual shortage: | 5 (7%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 1 (1%) | |
| Resolved: | 63 (91%) | |
Discontinuation Reports |
7 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 4 (57%) | |
| Reversed: | 3 (43%) | |
Late reports |
6 (8%) |
|
Overdue reports |
2 (40%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RIVOTRIL | 0.5MG | TABLET | Resolved | 2022-10-12 | 2023-04-01 | 171577 |
| RIVOTRIL | 2MG | TABLET | Resolved | 2022-10-12 | 2023-04-01 | 171580 |
| ANANDRON | 50MG | TABLET | Resolved | 2017-06-21 | 2017-07-06 | 13478 |
| ANANDRON | 50MG | TABLET | Resolved | 2019-11-21 | 2019-12-16 | 99378 |
| ANANDRON | 50MG | TABLET | Resolved | 2021-03-08 | 2021-06-16 | 135253 |
| ANANDRON | 50MG | TABLET | Resolved | 2023-09-14 | 2024-05-17 | 204346 |
| ANANDRON | 50MG | TABLET | Actual shortage | 2024-07-11 | 2024-08-08 | 232663 |
| INHIBACE PLUS | 5MG 12.5MG | TABLET | Resolved | 2021-01-04 | 2021-10-19 | 130792 |
| INHIBACE PLUS | 12.5MG 5MG | TABLET | Resolved | 2022-05-09 | 2022-05-25 | 160204 |
| INHIBACE PLUS | 12.5MG 5MG | TABLET | Resolved | 2022-08-17 | 2022-09-30 | 166884 |
| INHIBACE PLUS | 12.5MG 5MG | TABLET | Actual shortage | 2024-06-17 | 2024-09-16 | 230712 |
| ATACAND | 4MG | TABLET | Resolved | 2019-03-13 | 2019-04-11 | 78575 |
| ATACAND | 8MG | TABLET | Resolved | 2019-01-11 | 2019-03-14 | 71981 |
| ATACAND | 8MG | TABLET | Resolved | 2020-01-17 | 2020-01-25 | 103575 |
| ATACAND | 8MG | TABLET | Resolved | 2020-02-10 | 2020-03-07 | 105629 |
| ATACAND | 8MG | TABLET | Resolved | 2020-04-29 | 2020-05-14 | 113490 |
| ATACAND | 16MG | TABLET | Resolved | 2019-01-28 | 2019-04-11 | 73737 |
| ATACAND | 16MG | TABLET | Resolved | 2020-01-17 | 2020-01-25 | 103581 |
| ATACAND | 16MG | TABLET | Resolved | 2020-02-19 | 2020-03-07 | 106664 |
| ATACAND PLUS | 12.5MG 16MG | TABLET | Resolved | 2019-01-11 | 2019-03-14 | 71989 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| SUPREFACT DEPOT 2 MONTHS | 6.3MG | IMPLANT | Reversed | 2024-05-16 | 2024-06-19 | 228169 |
| SUPREFACT DEPOT 3 MONTHS | 9.45MG | IMPLANT | Reversed | 2024-05-16 | 2024-07-10 | 228166 |
| SUPREFACT | 100MCG | SOLUTION | Discontinued | 2021-12-13 | 2021-12-13 | 151039 |
| ANANDRON | 50MG | TABLET | Reversed | 2024-05-16 | 2024-07-10 | 228155 |
| XELODA | 150MG | TABLET | Discontinued | 2022-11-30 | 2022-12-01 | 176355 |
| XELODA | 500MG | TABLET | Discontinued | 2022-11-30 | 2022-12-01 | 176359 |
| LOSEC | 20MG | TABLET (DELAYED-RELEASE) | Discontinued | 2021-11-19 | 2021-11-19 | 149669 |
Showing 1 to 7 of 7